Skip to main content
Article thumbnail
Location of Repository

Differential Carbohydrate Recognition by Campylobacter jejuni Strain 11168: Influences of Temperature and Growth Conditions

By Christopher J. Day, Joe Tiralongo, Regan D. Hartnell, Carie-Anne Logue, Jennifer C. Wilson, Mark von Itzstein and Victoria Korolik

Abstract

The pathogenic clinical strain NCTC11168 was the first Campylobacter jejuni strain to be sequenced and has been a widely used laboratory model for studying C. jejuni pathogenesis. However, continuous passaging of C. jejuni NCTC11168 has been shown to dramatically affect its colonisation potential. Glycan array analysis was performed on C. jejuni NCTC11168 using the frequently passaged, non-colonising, genome sequenced (11168-GS) and the infrequently passaged, original, virulent (11168-O) isolates grown or maintained under various conditions. Glycan structures recognised and bound by C. jejuni included terminal mannose, N-acetylneuraminic acid, galactose and fucose. Significantly, it was found that only when challenged with normal oxygen at room temperature did 11168-O consistently bind to sialic acid or terminal mannose structures, while 11168-GS bound these structures regardless of growth/maintenance conditions. Further, binding of un-capped galactose and fucosylated structures was significantly reduced when C. jejuni was maintained at 25°C under atmospheric oxygen conditions. These binding differences identified through glycan array analysis were confirmed by the ability of specific lectins to competitively inhibit the adherence of C. jejuni to a Caco-2 intestinal cell line. Our data suggests that the binding of mannose and/or N-acetylneuraminic acid may provide the initial interactions important for colonisation following environmental exposure

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2654152
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). A method for the covalent capture and screening of diverse small molecules in a microarray format.
    2. (1998). A novel flow cytometric assay for quantitating adherence of Helicobacter pylori to gastric epithelial cells.
    3. (2008). Amino-acid dependent growth of Campylobacter jejuni: Key roles for aspartase (AspA) under microaerobic and oxygen-limited conditions and identification of AspB (Cj0762), essential for growth on glutamate.
    4. (1993). Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens.
    5. (2002). Bacterial adhesion to target cells enhanced by shear force.
    6. (2001). Bile-induced ‘pili’ in Campylobacter jejuni are bacteria-independent artifacts of the culture medium.
    7. (2007). Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon.
    8. (1996). Carbohydrate-lectin interactions in infectious disease.
    9. (2006). Carbohydrates as future anti-adhesion drugs for infectious diseases.
    10. (1994). Cell association and invasion of Caco-2 cells by Campylobacter jejuni.
    11. (2001). Characterization of a galactose specific adhesin of enteroaggregative Escherichia coli.
    12. (1988). Chemotactic behavior of Campylobacter jejuni.
    13. (2003). Colonisation phenotype and colonisation potential differences in Campylobacter jejuni strains in chickens before and after passage in vivo.
    14. (2001). Comparative study of glycosyltransferase activities in Caco-2 cells before and after enterocytic differentiation using lectin-affinity high-performance liquid chromatography.
    15. (2001). Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern.
    16. (1997). Epidemiologic and clinical features of Campylobacter jejuni infections.
    17. (1991). Epidemiology of Campylobacter enteritis.
    18. (2004). Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin.
    19. (2007). Galactose-specific fimbrial adhesin of enteroaggregative Escherichia coli: a possible aggregative factor.
    20. (2002). Galectins and cancer.
    21. (2006). Glycan microarray technologies: tools to survey host specificity of influenza viruses.
    22. (2005). Glycoprofiling with micro-arrays of glycoconjugates and lectins.
    23. (1998). Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging.
    24. (2002). Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation.
    25. (2005). Human milk glycans protect infants against enteric pathogens.
    26. (2004). Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants.
    27. (2005). Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea.
    28. (2005). Identification and characterization of binding properties of Helicobacter pylori by glycoconjugate arrays.
    29. (1986). Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates.
    30. (2007). Improved in vitro model systems for gastrointestinal infection by choice of cell line, pH, microaerobic conditions, and optimization of culture conditions.
    31. (2006). Interactions of the fucose-specific Pseudomonas aeruginosa lectin, PA-IIL, with mammalian glycoconjugates bearing polyvalent Lewis(a) and ABH blood group glycotopes.
    32. (2003). Lewis type 1 antigen synthase (beta3Gal-T5) is transcriptionally regulated by homeoproteins.
    33. (2007). MUC1 cell surface mucin is a critical element of the mucosal barrier to infection.
    34. (2008). Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and transsialidase activities.
    35. (2006). NGlycosylation of the MUC1 mucin in epithelial cells and secretions.
    36. (2001). O-glycosylation of the mucin type.
    37. (1998). Physiological activity of Campylobacter jejuni far below the minimal growth temperature.
    38. (2004). Printed covalent glycan array for ligand profiling of diverse glycan binding proteins.
    39. (2001). Sequential assignment and secondary structure of the triple-labelled carbohydrate-binding domain of papG from uropathogenic E.
    40. (2004). Sheardependent ‘stick-and-roll’ adhesion of type 1 fimbriated Escherichia coli.M o l
    41. (2006). Sialic acid-specific lectins: occurrence, specificity and function.
    42. (2002). Solid-phase synthesis of bleomycin A(5) and three monosaccharide analogues: exploring the role of the carbohydrate moiety in RNA cleavage.
    43. (1995). Strategies for the synthesis and screening of glycoconjugates. 1. A library of glycosylamines.
    44. (2002). Structural basis for oligosaccharide-mediated adhesion of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.
    45. (2003). Structural basis of calcium and galactose recognition by the lectin PA-IL of Pseudomonas aeruginosa.
    46. (2004). Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract.
    47. (2001). Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.
    48. (2000). Terminal glycosylation of cystic fibrosis airway epithelial cells.
    49. (2008). The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin.
    50. (2008). The galectin family and digestive disease.
    51. (2000). The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences.
    52. (2004). The genome-sequenced variant of Campylobacter jejuni NCTC 11168 and the original clonal clinical isolate differ markedly in colonization, gene expression, and virulence-associated phenotypes.
    53. (1999). The hemagglutinating activities of Pseudomonas aeruginosa lectins PA-IL and PA-IIL exhibit opposite temperature profiles due to different receptor types.
    54. (2001). The solution structure of PapGII from uropathogenic Escherichia coli and its recognition of glycolipid receptors.
    55. (2004). The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens.
    56. (2003). Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins.
    57. (2007). Varki A

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.